Invests in AI and medical tech startups with a focus on disrupting humanity's future through innovative, high-impact technologies.
A venture partnership investing in fund managers and founders building companies shaping the future of humanity. Our primary investment focus is into disruptive and emerging A.I. and Medical technology applications.
Key people at Modi Ventures.
Modi Ventures is a Houston-based venture capital firm focused on investing in early-stage startups at the intersection of artificial intelligence (AI), biology, and medical technology. Its mission is to back companies that are pioneering transformative technologies with the potential to disrupt and improve humanity’s future, particularly in health tech and precision medicine. The firm’s investment philosophy centers on identifying high-impact, science-driven innovations that leverage AI and biomedical advances to redefine diagnostics, therapeutics, and healthcare delivery. Key sectors include AI-driven drug discovery, digital biology, multi-omics, gene editing, and next-generation medical devices. Modi Ventures plays a significant role in the startup ecosystem by providing capital, strategic support, and access to a network of top-tier investors and partners, helping accelerate the growth of companies that push the boundaries of medicine and technology[1][2][6].
Founded in 2022 by Sahir Ali, Modi Ventures emerged with a clear focus on the convergence of technology and biology. Sahir Ali, an experienced entrepreneur and investor with a background in AI, cloud computing, and precision medicine, leads the firm as its general partner. The firm quickly gained traction by closing its inaugural Tech+Bio Fund I at $32 million, followed by a second oversubscribed fund of $88 million in 2025, bringing total assets under management to over $134 million. Modi Ventures has evolved to become a key player in Houston’s Texas Medical Center innovation ecosystem, partnering with other prominent investors and supporting startups that integrate AI with biomedical sciences to create breakthrough healthcare solutions[1][2][3][6].
Modi Ventures rides the accelerating trend of convergence between AI and life sciences, a sector poised for rapid growth due to advances in computational biology, gene editing, and precision medicine. The timing is critical as AI technologies mature and biomedical data expands exponentially, enabling new diagnostic and therapeutic modalities. Market forces such as increasing healthcare digitization, demand for personalized medicine, and rising investment in biotech innovation favor Modi Ventures’ focus. By backing companies that integrate AI with biology, Modi Ventures influences the broader ecosystem by fostering innovation hubs like Houston’s Texas Medical Center and catalyzing the translation of scientific breakthroughs into real-world medical solutions[2][3][6].
Looking ahead, Modi Ventures is positioned to deepen its impact by continuing to fund and build category-defining companies at the AI-biology interface. Trends such as multi-omics integration, AI-driven drug discovery, and cellular reprogramming will shape its investment focus. The firm’s growing capital base and strategic partnerships suggest it will expand its influence in both direct startup investments and venture fund allocations. As healthcare increasingly embraces AI and precision medicine, Modi Ventures’ role as a hybrid investor-builder will be pivotal in shaping the future of medicine and biotechnology innovation, fulfilling its mission to disrupt humanity’s future through high-impact technologies[2][6].
Key people at Modi Ventures.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jan 1, 2023 | Lapsi Health | $4.0M Seed | — | — |
| May 1, 2021 | Ahura | $2.0M Seed | — | 2.12 Angels, Forum Ventures, Oceans, Manish Patel |
